DI PUNZIO, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 342
EU - Europa 289
AS - Asia 92
AF - Africa 4
OC - Oceania 1
Totale 728
Nazione #
US - Stati Uniti d'America 341
IT - Italia 90
IE - Irlanda 79
SE - Svezia 65
CN - Cina 63
SG - Singapore 21
DE - Germania 14
GB - Regno Unito 14
BE - Belgio 11
FR - Francia 9
FI - Finlandia 4
CI - Costa d'Avorio 3
IN - India 3
RU - Federazione Russa 3
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CA - Canada 1
IR - Iran 1
JP - Giappone 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 728
Città #
Chandler 84
Dublin 68
Ann Arbor 64
Shanghai 22
Ashburn 19
Boardman 19
Singapore 14
Beijing 13
Princeton 12
Brussels 11
Dearborn 11
Colchester 8
Los Angeles 8
Parma 8
Gravina di Catania 7
Wilmington 7
Fontanellato 6
New York 6
Woodbridge 6
Des Moines 5
Avola 4
Bologna 4
Falls Church 4
Ferrara 4
Helsinki 4
Messina 4
Nanjing 4
Piacenza 4
Reggio Nell'emilia 4
Rome 4
Scafati 4
Trezzano Sul Naviglio 4
Abidjan 3
Bremen 3
Brescia 3
Houston 3
Jinan 3
Pune 3
Zhengzhou 3
Carpi 2
Dosolo 2
Fremont 2
Guangzhou 2
Kunming 2
Milan 2
Nanchang 2
Palermo 2
Pistoia 2
Redmond 2
Saint-Fons 2
Santa Clara 2
Slough 2
St Petersburg 2
Taiyuan 2
Baku 1
Berlin 1
Cambridge 1
Cape Town 1
Dallas 1
Elyria 1
Fuzhou 1
Garching 1
Gatchina 1
Gloucester 1
Hangzhou 1
Istanbul 1
La Jolla 1
Langhirano 1
Leawood 1
Lecce 1
Lidköping 1
Manchester 1
Marseille 1
Melbourne 1
Modena 1
Ningbo 1
Novara 1
Padova 1
Peterborough 1
Philadelphia 1
Rockville 1
Sabz 1
San Gregorio di Catania 1
Seattle 1
Stockholm 1
Tappahannock 1
Tokyo 1
Toronto 1
Vezzano sul Crostolo 1
Washington 1
Xian 1
Totale 534
Nome #
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 86
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 72
The power of yeast in modeling human mutations leading to mitochondrial disease:the case of ANT1, YARS2, DNM1L and LYRM7. 71
Saccharomyces cerevisiae as a model for the identification of beneficial molecules for mitochondrial diseases. 70
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 68
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 64
Research of potentially therapeutic molecules for Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 59
A yeast-based screening unravels potential therapeutic molecules for mitochondrial diseases associated with dominant ant1 mutations 59
A yeast-based repurposing approach for the treatment of mitochondrial DNA depletion syndromes led to the identification of molecules able to modulate the dNTP pool 52
Saccharomyces cerevisiae as a tool for studying mutations in nuclear genes involved in diseases caused by mitochondrial DNA instability 50
The power of yeast in modeling human mutations leading to mitochondrial disease 46
Study of the effects of potentially beneficial molecules on the mitochondrial dNTP pool in a model of Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 42
Yeast as a model system to propose therapies for Mitochondrial Complex III Deficiency 15
Totale 754
Categoria #
all - tutte 3.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.215


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202052 0 0 9 2 2 8 11 3 3 6 6 2
2020/202183 2 1 16 2 5 4 4 3 9 22 7 8
2021/2022110 9 3 0 16 6 20 4 8 2 4 5 33
2022/2023303 30 34 34 19 18 31 9 15 89 2 15 7
2023/2024140 15 13 6 12 9 20 10 9 4 12 11 19
2024/202546 9 14 23 0 0 0 0 0 0 0 0 0
Totale 754